A signaling network in phenylephrine-induced benign prostatic hyperplasia

Endocrinology

Volumn 150, Issue 8, 2009, Pages 3576-3583

  Kim, Jayoung ^a,b   Yanagihara, Yutaka ^c   Kikugawa, Tadahiko ^c   Ji, Mihee ^a   Tanji, Nozomu ^c   Masayoshi, Yokoyama ^c   Freeman, Michael R ^a,b,d  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d Enders Research Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN; PHENYLEPHRINE; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DNA MICROARRAY; HISTOPATHOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; BLOTTING, WESTERN; CELL LINE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENYLEPHRINE; PHOSPHORYLATION; PROSTATIC HYPERPLASIA; RATS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 67651177692     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2008-1782     Document Type: Article

References (48)

1. Jacobsen SJ, Girman CJ, Lieber MM 2001 Natural history of benign prostatic hyperplasia. Urology 58:5-16; discussion 16
2. Lee KL, Peehl DM 2004 Molecular and cellular pathogenesis of benign prostatic hyperplasia. J Urol 172:1784-1791
3. Untergasser G, Madersbacher S, Berger P 2005 Benign prostatic hyperplasia: age-related tissue-remodeling. Exp Gerontol 40:121-128
4. Cunha GR 2008 Mesenchymal-epithelial interactions: past, present, and future. Differentiation 76:578-586
5. Bhowmick NA, Neilson EG, Moses HL 2004 Stromal fibroblasts in cancer initiation and progression. Nature 432:332-337
6. Cunha GR, Hayward SW, Wang YZ, Ricke WA 2003 Role of the stromal microenvironment in carcinogenesis of the prostate. Int J Cancer 107:1-10
7. Ropiquet F, Giri D, Lamb DJ, Ittmann M 1999 FGF7 and FGF2 are increased in benign prostatic hyperplasia and are associated with increased proliferation. J Urol 162:595-599
8. Kramer G, Steiner GE, Handisurya A, Stix U, Haitel A, Knerer B, Gessl A, Lee C, Marberger M 2002 Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate 52:43-58
9. Steiner GE, Newman ME, Paikl D, Stix U, Memaran-Dagda N, Lee C, Marberger MJ 2003 Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate 56:171-182
10. Mori H, Maki M, Oishi K, Jaye M, Igarashi K, Yoshida O, Hatanaka M 1990 Increased expression of genes for basic fibroblast growth factor and transforming growth factor type beta 2 in human benign prostatic hyperplasia. Prostate 16:71-80
11. Golomb E, Kruglikova A, Dvir D, Parnes N, Abramovici A 1998 Induction of atypical prostatic hyperplasia in rats by sympathomimetic stimulation. Prostate 34:214-221
12. Rosenzweig N, Horodniceanu J, Abramovici A 2004 Phenylephrine-induced neurogenic prostatitis facilitates the promotion of PIN-like lesions in rats. Prostate 59:107-113
13. Chung LW, Chang SM, Bell C, Zhau HE, Ro JY, von Eschenbach AC 1989 Co-inoculation of tumorigenic rat prostate mesenchymal cells with non-tumorigenic epithelial cells results in the development of carcinosarcoma in syngeneic and athymic animals. Int J Cancer 43:1179-1187
14. Soker S, Kaefer M, Johnson M, Klagsbrun M, Atala A, Freeman MR 2001 Vascular endothelial growth factor-mediated autocrine stimulation of prostate tumor cells coincides with progression to a malignant phenotype. Am J Pathol 159:651-659
15. Scaltriti M, Bettuzzi S, Sharrard RM, Caporali A, Caccamo AE, Maitland NJ 2004 Clusterin overexpression in both malignant and nonmalignant prostate epithelial cells induces cell cycle arrest and apoptosis. Br J Cancer 91:1842-1850
16. Scaltriti M, Santamaria A, Paciucci R, Bettuzzi S 2004 Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells1. Cancer Res 64:6174-6182
17. Marinese D, Patel R, Walden PD 2003 Mechanistic investigation of the adrenergic induction of ventral prostate hyperplasia in mice. Prostate 54:230-237
18. Jones SE, Jomary C 2002 Clusterin. Int J Biochem Cell Biol 34:427-431
19. Wilson MR, Easterbrook-Smith SB 2000 Clusterin is a secreted mammalian chaperone. Trends Biochem Sci 25:95-98
20. Shannan B, Seifert M, Leskov K, Willis J, Boothman D, Tilgen W, Reichrath J 2006 Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ 13:12-19
21. Schmitz G 2006 Drug evaluation: OGX-011, a clusterin-inhibiting antisense oligonucleotide. Curr Opin Mol Ther 8:547-554
22. Kramer G, Mitteregger D, Marberger M 2007 Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol 51:1202-1216
23. Bettuzzi S, Hiipakka RA, Gilna P, Liao ST 1989 Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis. Biochem J 257:293-296
24. Miyazono K, ten Dijke P, Heldin CH 2000 TGF-β signaling by Smad proteins. Adv Immunol 75:115-157
25. Brown KA, Pietenpol JA, Moses HL 2007 A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-β signaling. J Cell Biochem 101:9-33
26. Mahapokai W, Van Sluijs FJ, Schalken JA 2000 Models for studying benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 3:28-33
27. Broderick GA, Longhurst PA, Juniewicz PE, Wein AJ, Levin RM 1994 A novel canine model of partial outlet obstruction secondary to prostatic hypertrophy. World J Urol 12:245-248
28. Muller WJ, Lee FS, Dickson C, Peters G, Pattengale P, Leder P 1990 The int-2 gene product acts as an epithelial growth factor in transgenic mice. EMBO J 9:907-913
29. Konno-Takahashi N, Takeuchi T, Shimizu T, Nishimatsu H, Fukuhara H, Kamijo T, Moriyama N, Tejima S, Kitamura T 2003 Engineered IGF-I expression induces glandular enlargement in the murine prostate. J Endocrinol 177:389-398
30. Konno-Takahashi N, Takeuchi T, Nishimatsu H, Kamijo T, Tomita K, Schalken JA, Teshima S, Kitamura T 2004 Engineered FGF-2 expression induces glandular epithelial hyperplasia in the murine prostatic dorsal lobe. Eur Urol 46:126-132
31. Tutrone Jr RF, Ball RA, Ornitz DM, Leder P, Richie JP 1993 Benign prostatic hyperplasia in a transgenic mouse: a new hormonally sensitive investigatory model. J Urol 149:633-639
32. Prakash K, Pirozzi G, Elashoff M, Munger W, Waga I, Dhir R, Kakehi Y, Getzenberg RH 2002 Symptomatic and asymptomatic benign prostatic hyperplasia: molecular differentiation by using microarrays. Proc Natl Acad Sci USA 99:7598-7603
33. Luo J, Dunn T, Ewing C, Sauvageot J, Chen Y, Trent J, Isaacs W 2002 Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis. Prostate 51:189-200
34. Alonso-Magdalena P, BrössnerC, Reiner A, Cheng G, Sugiyama N, Warner M, Gustafsson JA 2009 A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia. Proc Natl Acad Sci USA 106:2859-2863
35. Miyake H, Hara I, Gleave ME 2005 Antisense oligodeoxynucleotide therapy targeting clusterin gene for prostate cancer: Vancouver experience from discovery to clinic. Int J Urol 12:785-794
36. Hough CD, Cho KR, Zonderman AB, Schwartz DR, Morin PJ 2001 Coordinately up-regulated genes in ovarian cancer. Cancer Res 61:3869-3876
37. Kurahashi T, Muramaki M, Yamanaka K, Hara I, Miyake H 2005 Expression of the secreted form of clusterin protein in renal cell carcinoma as a predictor of disease extension. BJU Int 96:895-899
38. Scaltriti M, Brausi M, Amorosi A, Caporali A, D'Arca D, Astancolle S, Corti A, Bettuzzi S 2004 Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer. Int J Cancer 108:23-30
39. Bettuzzi S, Davalli P, Astancolle S, Carani C, Madeo B, Tampieri A, Corti A, Saverio B, Pierpaola D, Serenella A, Cesare C, Bruno M, Auro T, Arnaldo C 2000 Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. Cancer Res 60:28-34
40. Behrens P, Jeske W, Wernert N, Wellmann A 2001 Downregulation of clusterin expression in testicular germ cell tumours. Pathobiology 69:19-23
41. De Marzo AM, Marchi VL, Epstein JI, Nelson WG 1999 Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155:1985-1992
42. Sciarra A, Di Silverio F, Salciccia S, Autran Gomez AM, Gentilucci A, Gentile V 2007 Inflammation and chronic prostatic diseases: evidence for a link? Eur Urol 52:964-972
43. Kramer G, Marberger M 2006 Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr Opin Urol 16:25-29
44. Lee KB, Jeon JH, Choi I, Kwon OY, Yu K, You KH 2008 Clusterin, a novel modulator of TGF-β signaling, is involved in Smad2/3 stability. Biochem Biophys Res Commun 366:905-909
45. Cross NA, Reid SV, Harvey AJ, Jokonya N, Eaton CL 2006 Opposing actions of TGFβ1 and FGF2 on growth, differentiation and extracellular matrix accumulation in prostatic stromal cells. Growth Factors 24:233-241
46. Giri D, Ittmann M 2001 Interleukin-8 is a paracrine inducer of fibroblast growth factor 2, a stromal and epithelial growth factor in benign prostatic hyperplasia. Am J Pathol 159:139-147
47. Castro P, Xia C, Gomez L, Lamb DJ, Ittmann M 2004 Interleukin-8 expression is increased in senescent prostatic epithelial cells and promotes the development of benign prostatic hyperplasia. Prostate 60:153-159
48. Schauer IG, Ressler SJ, Tuxhorn JA, Dang TD, Rowley DR 2008 Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia. Urology 72:205-213